| Members |
targetComponentId |
| Mouse mix radioallergosorbent test |
Mouse epithelium, serum proteins and urine proteins specific IgE antibody measurement |
| Moved elsewhere |
Moved elsewhere |
| Moxifloxacin hydrochloride |
Product containing moxifloxacin (medicinal product) |
| Moxifloxacin hydrochloride 0.5% ophthalmic solution |
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Moxifloxacin hydrochloride 1.6mg/mL infusion solution 250mL bag |
Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection |
| Mucinous cystadenoma, borderline malignancy |
Mucinous cystic tumor of borderline malignancy |
| Mucinous cystic tumor with moderate dysplasia |
Mucinous cystadenoma |
| Mucoid otitis media |
Chronic mucoid otitis media |
| Mucolytics adverse reaction |
Adverse reaction to drug |
| Mucosal-associated lymphoid tissue (MALT) lymphoma |
Marginal zone B-cell lymphoma |
| Mucositis following chemotherapy |
Inflammation of mucous membrane due to and following chemotherapy |
| Mucous membrane anti-infective |
Anti-infective agent (substance) |
| Mulberry molar |
Moon's molar teeth |
| Mullet - dietary |
Mullet (substance) |
| Multiceps |
Taenia |
| Multiceps |
Taenia |
| Multiceps brauni |
Taenia brauni |
| Multiceps serialis |
Taenia serialis (organism) |
| Multicystic kidney |
Multicystic renal dysplasia |
| Multiple V-Y plasties |
Reconstruction of skin using local V-Y advancement flap (procedure) |
| Multiple closed fractures of skull AND/OR face with cerebral laceration AND/OR contusion |
Traumatic brain injury |
| Multiple closed fractures of skull and face with intracranial injury of other and unspecified nature |
Injury of head |
| Multiple closed fractures of skull and face with other and unspecified intracranial hemorrhage |
Injury of head |
| Multiple complications due to diabetes mellitus |
Complication due to diabetes mellitus (disorder) |
| Multiple complications due to malnutrition related diabetes |
Disorder due to malnutrition related diabetes mellitus |
| Multiple complications due to type 1 diabetes mellitus |
Disorder due to type 1 diabetes mellitus |
| Multiple complications due to type 2 diabetes mellitus |
Disorder due to type 2 diabetes mellitus (disorder) |
| Multiple complications of type II diabetes mellitus |
Disorder due to type 2 diabetes mellitus (disorder) |
| Multiple congenital articular rigidities |
Congenital amyoplasia (disorder) |
| Multiple electrolyte infusion allergy |
Allergy to drug |
| Multiple endocrine deficiency syndrome, NEC |
Multiple endocrine deficiency syndrome |
| Multiple extreme injuries of abdominal organs with open wound into cavity |
Severe crushing injury of abdominal organs with open wound into cavity |
| Multiple extreme injuries of abdominal organs without open wound into cavity |
Severe crushing injury of abdominal organs without open wound into cavity |
| Multiple myeloma |
Multiple myeloma |
| Multiple myeloma, no International Classification of Diseases for Oncology subtype |
Plasma cell myeloma |
| Multiple non-ossifying fibromatosis |
Neurofibromatosis type 1 |
| Multiple open fractures of skull and face with intracranial injury of other and unspecified nature |
Injury of head |
| Multiple open fractures of skull and face with other and unspecified intracranial hemorrhage |
Injury of head |
| Multiple pregnancy with malpresentation NOS |
Multiple pregnancy with malpresentation |
| Multiple pregnancy with malpresentation unspecified |
Multiple pregnancy with malpresentation |
| Multiple-level cervical spondylosis with myelopathy |
Myelopathy due to multiple-level cervical spondylosis (disorder) |
| Multiple-level cervical spondylosis with radiculopathy |
Radiculopathy due to multiple-level cervical spondylosis |
| Mumps with other specified complication |
Mumps with complication |
| Mumps-measles-rubella not given |
Measles mumps and rubella vaccination not done (situation) |
| Mupirocin calcium 2% cream |
Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream |
| Mural cardiac aneurysm |
Aneurysm of heart |
| Mural cardiac aneurysm |
Aneurysm of heart |
| Muscle bridge |
Reconstruction using flap (procedure) |
| Muscle transfer for claw toe repair |
Transfer of flexor to extensor tendon of lesser toe |
| Muscular calcification |
Muscular ossification |
| Muscular wasting and disuse atrophy, NEC |
Muscle atrophy |
| Musculoskel X-ray abnorm [D] |
X-ray of musculoskeletal system abnormal |
| Musculoskeletal system diagnostic imaging procedure |
Imaging of musculoskeletal system (procedure) |
| Mushroom |
Order Agaricales |
| Mushroom - dietary |
Mushroom (substance) |
| Mustard - dietary |
Mustard seasoning (substance) |
| Mutase |
Mutase |
| Mycobacterium aquae |
Mycobacterium gordonae |
| Mycobacterium bolletii |
Mycobacteroides abscessus subspecies abscessus (organism) |
| Mycobacterium chelonae ss. abscessus |
Mycobacteroides abscessus (organism) |
| Mycobacterium chlorophenolicus |
Mycobacterium chlorophenolicum |
| Mycobacterium margeritense |
Mycobacterium mageritense (organism) |
| Mycobacterium, MAIS group |
Mycobacterium, avium-intracellulare group |
| Mycophenolic acid 180mg m/r capsule |
Mycophenolic acid (as mycophenolate sodium) 180 mg gastro-resistant oral tablet |
| Mycophenolic acid 360mg m/r capsule |
Mycophenolic acid (as mycophenolate sodium) 360 mg gastro-resistant oral tablet |
| Mycoplana bullata |
Brevundimonas bullata (organism) |
| Mycoplasma ellychniae |
Entomoplasma ellychniae |
| Mycoplasma lactucae |
Mesoplasma lactucae |
| Mycoplasma lepcaptivus |
Mycoplasma leonicaptivi (organism) |
| Mycoplasma lucivorax |
Entomoplasma lucivorax |
| Mycoplasma melaleucae |
Entomoplasma melaleucae |
| Mycoplasma somnilux |
Entomoplasma somnilux |
| Mycoplasma weynonii |
Mycoplasma wenyonii (organism) |
| Mycosis fungoides of extranodal AND/OR solid organ site |
Mycosis fungoides (clinical) |
| Mycosis fungoides of lymph nodes of axilla AND/OR upper limb |
Mycosis fungoides of lymph nodes of upper limb (disorder) |
| Mycosis fungoides of lymph nodes of axilla and upper limb |
Mycosis fungoides of lymph nodes of upper limb (disorder) |
| Mycosis leptothrica |
Tonsillitis caused by Gram negative bacteria |
| Mycotic aneurysm due to bacterial endocarditis |
Endocarditis with infective aneurysm |
| Myelinated retinal nerve fibres |
Myelinated nerve fiber layer of retina |
| Myelinated retinal nerve fibres |
Myelinated nerve fiber layer of retina |
| Myelodysplasia |
Myelodysplasia of spinal cord |
| Myelodysplastic syndrome with multilineage dysplasia |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic syndrome with multilineage dysplasia |
Myelodysplastic neoplasm with low blasts (morphologic abnormality) |
| Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic syndrome with single lineage dysplasia |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic syndrome with single lineage dysplasia |
Myelodysplastic neoplasm with low blasts (morphologic abnormality) |
| Myelodysplastic syndrome: Refractory anemia, without ringed sideroblasts, without excess blasts |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myeloid leukemia - category |
Myeloid leukaemia |
| Myeloid leukemia, no International Classification of Diseases for Oncology subtype |
Myeloid leukaemia |
| Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement |
Myeloid/lymphoid neoplasm with PDGFRB rearrangement |
| Myeloproliferative disease, no ICD-O subtype |
Myeloid proliferation |
| Myelosclerosis |
Myelofibrosis |
| Myelosclerosis with myeloid metaplasia |
Primary myelofibrosis |
| Myocardial infarction clinical management plan |
Myocardial infarction clinical management plan (record artifact) |
| Myoma, no International Classification of Diseases for Oncology subtype |
Myoma |
| Myometrial hyperplasia |
Hyperplasia of myometrium (disorder) |
| Myotenontoplasty |
Myotenoplasty |
| Myotenoplasty of hand |
Myotenoplasty |
FHIR